Heparanase-1 facilitates bone remodeling on bone defect animal model with optimal dosage and treatment duration
- PMID: 32649419
- PMCID: PMC7478219
- DOI: 10.1097/JCMA.0000000000000391
Heparanase-1 facilitates bone remodeling on bone defect animal model with optimal dosage and treatment duration
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
Comment in
-
Does exogenously adding heparanase accelerate bone healing?J Chin Med Assoc. 2020 Nov;83(11):975-976. doi: 10.1097/JCMA.0000000000000432. J Chin Med Assoc. 2020. PMID: 32947507 Free PMC article. No abstract available.
Comment on
-
Topical application of Heparanase-1 facilitates bone remodeling during the healing of bone defects in a mouse model.J Chin Med Assoc. 2020 Mar;83(3):272-279. doi: 10.1097/JCMA.0000000000000261. J Chin Med Assoc. 2020. PMID: 31985568
References
-
- Han Z, Bhavsar M, Leppik L, Oliveira KMC, Barker JH. Histological scoring method to assess bone healing in critical size bone defect models. Tissue Eng Part C Methods 2018;24:272–9. - PubMed
-
- El-Rashidy AA, Roether JA, Harhaus L, Kneser U, Boccaccini AR. Regenerating bone with bioactive glass scaffolds: a review of in vivo studies in bone defect models. Acta Biomater 2017;62:1–28. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
